Journal of Medical - Clinical Research & Reviews

Journal of Medical - Clinical Research & Reviews

Open Access
ISSN: 2639-944X
Case Report

Recurrent Immune Thrombocytopenic Purpura in a Pediatric Patient: A Case of Viral-Triggered Autoimmunity and Therapeutic Challenges

Authors: Miguel Guillermo Garber, Felix Pedrero Ramallo.

DOI: 10.33425/2639-944X.1427


Abstract

We report a case of refractory idiopathic thrombocytopenic purpura (ITP) in a patient with recurrent relapses despite conventional therapy, including corticosteroid tapering (deflazacort), adjuvant pimotimod (for recurrent infections and allergic rhinitis), and repeated intravenous immunoglobulin (IVIG) infusions. Platelet counts exhibited poor correlation with deflazacort dosing, and disease progression was complicated by allergic sensitization (Alternaria, bee venom), resulting in a torpid clinical course. Following limited response to standard therapies, an integrative approach was initiated using the natural supplement StemRegén (Aphanizomenon flos-aquae, AFA). After two months of oral administration, a progressive and sustained increase in platelet count was observed, with no significant adverse effects. This case suggests a potential immunomodulatory and platelet-stimulating effect of AFA, warranting further investigation into its role as an adjunctive therapy in refractory ITP. These findings highlight the need for exploring unconventional therapeutic strategies in patients with poor response to traditional treatments.

View / Download PDF
Citation: Miguel Guillermo Garber,  Felix Pedrero Ramallo. Recurrent Immune Thrombocytopenic Purpura in a Pediatric Patient: A Case of Viral-Triggered Autoimmunity and Therapeutic Challenges. 2025; 9(8). DOI: 10.33425/2639-944X.1427
Editor-in-Chief
Sara Badia
Sara Badia
Cardiac Surgery Department | Germans Trias University Hospital in Pujol

View full editorial board →
Journal Metrics
Impact Factor 1.84
Acceptance Rate 90%
Time to first decision 6-10 Days
Submission to acceptance 12-15 Days